1. Combined DNA Methylation and Gastric Microbiome Marker Predicts Helicobacter pylori-Negative Gastric Cancer.
- Author
-
Kim, Min-Jeong, Kim, Han-Na, Jacobs, Jonathan, and Yang, Hyo-Joon
- Subjects
16S ,Biomarkers ,DNA methylation ,Gastrointestinal microbiome ,RNA ,Stomach neoplasms ,ribosomal ,Humans ,Male ,DNA Methylation ,Female ,Stomach Neoplasms ,Middle Aged ,Case-Control Studies ,Helicobacter pylori ,Gastric Mucosa ,Gastrointestinal Microbiome ,Twist-Related Protein 1 ,Aged ,MicroRNAs ,Nuclear Proteins ,Gastritis ,Biomarkers ,Tumor ,RNA ,Ribosomal ,16S ,Helicobacter Infections ,Metaplasia ,Adaptor Proteins ,Signal Transducing ,Adult ,Intercellular Signaling Peptides and Proteins ,Homeodomain Proteins - Abstract
BACKGROUND/AIMS: While DNA methylation and gastric microbiome are each associated with gastric cancer (GC), their combined role in predicting GC remains unclear. This study investigated the potential of a combined DNA methylation and gastric microbiome signature to predict Helicobacter pylori-negative GC. METHODS: In this case-control study, we conducted quantitative methylation-specific polymerase chain reaction to measure the methylation levels of DKK3, SFRP1, EMX1, NKX6-1, MIR124-3, and TWIST1 in the gastric mucosa from 75 H. pylori-negative patients, including chronic gastritis (CG), intestinal metaplasia (IM), and GC. A combined analysis of DNA methylation and gastric microbiome, using 16S rRNA gene sequencing, was performed in 30 of 75 patients. RESULTS: The methylation levels of DKK3, SFRP1, EMX1, MIR124-3, and TWIST1 were significantly higher in patients with GC than in controls (all q
- Published
- 2024